Both in Biotechnology
Fennec Pharmaceuticals vs Allogene Therapeutics
Over the past year FENC returned +20.2% and ALLO returned +2.0%; their daily moves had a correlation of 0.17.
FENC +20.2% ALLO +2.0%Growth of $1, one year, split-adjusted
| Metric | FENC | ALLO |
|---|---|---|
| Price | $10.53 | $1.29 |
| Market cap | $369.3M | $444.0M |
| Today | −0.85% | +4.47% |
| 1 month | −2.5% | −20.7% |
| 6 months | +68.2% | −39.1% |
| Year to date | +36.8% | −6.2% |
| 1 year | +19.4% | +4.5% |
| Revenue growth (YoY) | +85.2% | — |
| Gross margin | 96.0% | 100.0% |
| Net margin | 11.0% | −919.8% |
| P/E (TTM) | — | — |
| Price / sales | 6.2× | 95.7× |
| Net cash | $41.2M | $332.6M |
| Dividend yield | — | — |
| Volatility (60d) | 56.6% | 52.1% |
| Short % of float | 2.2% | 19.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).